Real-time enrollment status for this neoplasm metastasis clinical trial
Current Status
Recruiting
Checked: October 28, 2026 at 6:55 PM UTC
| NCT Number | NCT04886804 |
| Recruiting Status | Recruiting |
| Condition | Neoplasm Metastasis |
| Phase | PHASE1 |
| Target Enrollment | 554 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | October 28, 2026 (18 hours ago) |
As of October 28, 2026: Clinical trial NCT04886804 is currently recruiting participants. This phase1 study for neoplasm metastasis is actively seeking new participants at 20 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04886804 is actively recruiting participants as of October 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04886804 was last updated 18 hours ago (October 28, 2026). HelloStudys verifies this status automatically.